Get alerts on new PUREBLISS PHARMA SOLUTIONS PRIVATE LIMITED bonds
Top yield
17.75%
latest traded
Trading now
1
of 1 live
Instruments
1
outstanding
Top rating
—
latest
| The latest agency surveillance grade where one is on record; otherwise the grade at issue. A rating can migrate after issuance, so the two can differ. | ||||
|---|---|---|---|---|
Purebliss Pharma SolutionsINE30PK07010NCD | — | 16.47% | 25 Sept 20292.9y left | 17.75% |
Click any security to compare it across platforms against the live exchange-traded yield. A blank yield means no recent trade, not no value.
Keep exploring
Comparisons
Sammaan Capital14 buyable · up to 9.45%
Indel Money11 buyable · up to 12.15%
Navi Finserv11 buyable · up to 11.00%
Kosamattam Finance11 buyable · up to 10.70%
Keertana Finserv10 buyable · up to 12.40%
Insights
- Rating actions
upgrades & downgrades
- G-Sec yield curve
- Debt market review
- How to play the tenor
Guide · part 2
Capera
Neutrality
Guarantee
Neutrality guarantee
Prices you can't pay to move.
Capera is editorially independent. We may earn from the platforms and institutions we list, but a commercial arrangement never changes the price or yield we show you.